Harvey Capital Management’s Colgate-Palmolive CL Stock Holding History

Harvey Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,000	Closed	-$301K	–	82
2017 Q4	$301K	Hold	4,000	–	–	0.11%	71
2017 Q3	$291K	Hold	4,000	–	–	0.12%	67
2017 Q2	$296K	Hold	4,000	–	–	0.13%	68
2017 Q1	$292K	Hold	4,000	–	–	0.13%	64
2016 Q4	$261K	Hold	4,000	–	–	0.12%	70
2016 Q3	$296K	Hold	4,000	–	–	0.09%	62
2016 Q2	$292K	Hold	4,000	–	–	0.15%	61
2016 Q1	$282K	Hold	4,000	–	–	0.14%	63
2015 Q4	$266K	Hold	4,000	–	–	0.11%	70
2015 Q3	$253K	Hold	4,000	–	–	0.1%	74
2015 Q2	$264K	Hold	4,000	–	–	0.09%	77
2015 Q1	$277K	Hold	4,000	–	–	0.1%	72
2014 Q4	$276K	Hold	4,000	–	–	0.11%	66
2014 Q3	$260K	Hold	4,000	–	–	0.1%	65
2014 Q2	$272K	Hold	4,000	–	–	0.1%	66
2014 Q1	$259K	Hold	4,000	–	–	0.1%	67
2013 Q4	$260K	Buy	+4,000	New	+$256K	0.11%	73

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Harvey Capital Management's CL Position: Q1 2018 in Review

Harvey Capital Management sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 4,000 shares — an estimated $301K sold.

Harvey Capital Management first reported a position in CL in Q4 2013 and held it in 17 quarters. The position peaked at $301K in Q4 2017. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Harvey Capital Management reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Harvey Capital Management sold 4,000 Colgate-Palmolive shares in Q1 2018, an estimated $301K.
Harvey Capital Management first reported a position in Colgate-Palmolive in Q4 2013 and held it in 17 quarters.
Harvey Capital Management's Colgate-Palmolive position peaked at $301K in Q4 2017.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Harvey Capital Management's 13F filing for Q1 2018, filed 27 Apr 2018.